Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
strategic options
Biotech
After 3rd phase 3 strike, Relmada's depression drug is out
The biotech is looking into a broad range of paths forward, including a merger or reverse merger, buying or selling assets, or selling the company.
Darren Incorvaia
Dec 9, 2024 2:30pm
Portage Biotech hints at potential closure as it halts programs
Apr 12, 2024 10:22am
Cash-strapped Gamida steps up search for strategic alternatives
Jan 29, 2024 8:41am
SQZ lays off 80% of staff, Regenxbio cuts 15%
Nov 9, 2023 8:23am
Genetic medicines biotech to cease operations by end of year
Nov 2, 2023 3:15pm
Impel works to stave off bankruptcy, puts itself up for sale
Oct 5, 2023 11:16am
